DBPR112
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-128778-5MG | 5 mg | 456,00 | Add | |
| HY-128778-10MMO | 10mM/1mL | 534,00 | Add | |
| HY-128778-10MG | 10 mg | 837,00 | Add | |
| HY-128778-25MG | 25 mg | 1'634,00 | Add | |
| HY-128778-50MG | 50 mg | 2'484,00 | Add | |
| HY-128778-100MG | 100 mg | 3'750,00 | Add | |
| HY-128778-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
DBPR112 is an orally active furanopyrimidine-based EGFR inhibitor with IC50s of 15 nM and 48 nM for EGFRWT and EGFRL858R/T790M, respectively. DBPR112 can occupy the ATP-binding site. DBPR112 has significant antitumor efficacy[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, JAK/STAT Signaling,Protein Tyrosine Kinase/RTK |
| Format | Solubility: DMSO : 250 mg/mL (ultrasonic) |
| Grade | Clinical information: Phase 1 |
| Purity | 98.37% |
| Molecular Formula | C32H31N5O3 |
| Molecular Weight | 533.62 |
| CAS-Number | 1226549-49-0 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
